These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The best screening test for colorectal cancer--a personal choice. Woolf SH N Engl J Med; 2000 Nov; 343(22):1641-3. PubMed ID: 11096175 [No Abstract] [Full Text] [Related]
24. Screening for colorectal cancer: recommendation and rationale. U.S. Preventive Services Task Force Am Fam Physician; 2002 Dec; 66(12):2287-90. PubMed ID: 12507168 [No Abstract] [Full Text] [Related]
25. Colorectal cancer screening and surveillance: current standards and future trends. Martinez SR; Young SE; Hoedema RE; Foshag LJ; Bilchik AJ Ann Surg Oncol; 2006 Jun; 13(6):768-75. PubMed ID: 16604473 [TBL] [Abstract][Full Text] [Related]
26. Screening for colorectal cancer: the business case. Fletcher RH; Colditz GA; Pawlson LG; Richman H; Rosenthal D; Salber PR Am J Manag Care; 2002 Jun; 8(6):531-8. PubMed ID: 12068960 [TBL] [Abstract][Full Text] [Related]
27. Clinical practice guidelines. Review of the recommendations for colorectal screening. Anderson J Geriatrics; 2000 Feb; 55(2):67-73; quiz 74. PubMed ID: 10711308 [TBL] [Abstract][Full Text] [Related]
28. A comparison of three stool tests for colorectal cancer screening. Greenwald B Medsurg Nurs; 2005 Oct; 14(5):292-9; quiz 300. PubMed ID: 16318108 [TBL] [Abstract][Full Text] [Related]
29. Current colorectal cancer screening strategies: overview and obstacles to implementation. Rex DK Rev Gastroenterol Disord; 2002; 2 Suppl 1():S2-11. PubMed ID: 12439393 [TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach. Wong SS; Leong AP; Leong TY Stud Health Technol Inform; 2004; 107(Pt 1):104-10. PubMed ID: 15360784 [TBL] [Abstract][Full Text] [Related]
32. The detection of colorectal cancer at an asymptomatic stage by screening is useful. Komuta K; Furui J; Haraguchi M; Kanematsu T Hepatogastroenterology; 2000; 47(34):1011-4. PubMed ID: 11020866 [TBL] [Abstract][Full Text] [Related]
33. Evaluation and therapy of the patient with fecal occult blood loss: a decision analysis. Lashner BA; Silverstein MD Am J Gastroenterol; 1990 Sep; 85(9):1088-95. PubMed ID: 2117850 [TBL] [Abstract][Full Text] [Related]
34. Colorectal carcinoma screening procedure use among primary care patients. Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119 [TBL] [Abstract][Full Text] [Related]
35. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment. Jones RM; Mongin SJ; Lazovich D; Church TR; Yeazel MW Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):777-84. PubMed ID: 18381476 [TBL] [Abstract][Full Text] [Related]
36. From guaiac to immune fecal occult blood tests: the emergence of technology in colorectal cancer screening. Greenwald B Gastroenterol Nurs; 2005; 28(2):90-6. PubMed ID: 15832108 [TBL] [Abstract][Full Text] [Related]
37. Judging the guidelines for colorectal cancer screening. Woolf SH; Ganiats TG Am Fam Physician; 1997 Jun; 55(8):2595, 2598-600. PubMed ID: 9191445 [No Abstract] [Full Text] [Related]
38. Colorectal cancer screening. Borum ML Prim Care; 2001 Sep; 28(3):661-74, viii. PubMed ID: 11483450 [TBL] [Abstract][Full Text] [Related]